POLYMED — Poly Medicure Income Statement
0.000.00%
Last trade - 00:00
- IN₹150.03bn
- IN₹148.44bn
- IN₹11.15bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,108 | 6,872 | 7,865 | 9,231 | 11,152 |
Cost of Revenue | |||||
Gross Profit | 3,387 | 4,016 | 4,500 | 4,898 | 6,059 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,186 | 5,637 | 6,196 | 7,639 | 9,067 |
Operating Profit | 922 | 1,235 | 1,669 | 1,591 | 2,085 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,001 | 1,257 | 1,801 | 1,952 | 2,375 |
Provision for Income Taxes | |||||
Net Income After Taxes | 654 | 959 | 1,359 | 1,465 | 1,793 |
Net Income Before Extraordinary Items | |||||
Net Income | 654 | 959 | 1,359 | 1,465 | 1,793 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 654 | 959 | 1,359 | 1,465 | 1,793 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.35 | 10.9 | 15.2 | 15.2 | 18.7 |
Dividends per Share |